Professional Documents
Culture Documents
Binns et a1.
(54)
5,724,379 A
SYSTEM
5,809,478 A *
9/1998
Inventors:
5,873,066 A
5,893,072 A
(Us)
Subject to any disclaimer, the term of this
patent is extended or adjusted under 35
Notice:
Greco et al.
................. .. 705/4
11/1998 Dang
2/1999 Underwood et a1.
4/1999 Zizzamia
(Continued)
5,835,897 A
(75)
US 7,392,201 B1
OTHER PUBLICATIONS
Anonymous, Medical Scientists Inc. Selects MEDSTAT for 3 Year
(Continued)
(22)
Filed:
(60)
(57)
(51)
ABSTRACT
Int. Cl.
G06Q 40/00
G06Q 50/00
G06F 19/00
A61B 5/00
(2006.01)
(2006.01)
(2006.01)
(2006.01)
705/4; 705/2; 705/3; 600/300
(52)
(58)
(56)
References Cited
705/4
4,667,292
4,975,840
5,018,067
5,544,044
5,557,514
5,613,072
5,652,842
5,712,984
A
5/1987 Mohlenbrock et a1.
A * 12/1990 DeTore et a1. ................ ..
A
5/1991 Mohlenbrock et a1.
A
8/1996 Leatherman
A
9/1996 Seare et a1.
A
3/1997 Hammond et a1. ........... ..
A
7/1997 Siegrist, Jr. et a1.
A
1/1998 Hammond et a1.
Prlce Opilmllatloll
I302
Chem lnmn
Grow
cos!
eslimzte
1
v
eulale
Expened FmmMarqm
d?ferem me mzreases
Retention unve
Admimstra?ve costs
Minimun awlvlihle mm
margin
J 1
Rm
assumption
was
is maxlmum nmm
n
acceptable?
0mm wuss
mm
and remminer
essumnl/ons
US 7,392,201 B1
Page 2
US. PATENT DOCUMENTS
5,918,208 A
5,970,464 A
6/1999 Javitt
10/1999 Apte et al.
5,976,082 A *
stats/ss95both.xls.
tion, G. Thomas Ray, et al., Medical Care Research and Review, vol.
57 No. 1, (Mar. 2000), pp. 92-109.
Potentials and Limitations of Database Research, M.S. Blumberg,
Statistics in Medicine, vol. 10, No. 4, p. 637.
Disaggregated Annual Health Services Expenditures: Their Predict
ability and Role as Predictors, Annemarie V. Wouters, Health Ser
vices Research, V. 26, pp. 247-272, Jun. 1991.
Extracting More Pro?ts from Small Group Renewals presentation to
Conseco Health, G. Binns, et al., Dec. 7, 1999.
Mining the Data for Smarter Renewals presentation to Fortis, G.
Binns, Nov. 15, 1999.
* cited by examiner
6,061,657 A
5/2000 Whiting-OKeefe
6,078,890 A
6,223,164 B1*
4/2001
OTHER PUBLICATIONS
hcfa.gov/stats/drg95dsc.xls.
Development & Evaluation of Clinical Risk Groups (CRGs), R.F.
Averill, et al., HIS Research Report Sep. 1999, http://WWWhcfagov/
US. Patent
Sheet 1 0f 13
US 7,392,201 B1
102
DATA:
Collection,
cleansing, integration
and aggregation.
l
104
Forecasting analysis
requires new model
or updating?
YES
106
NO
current Cost
Forecasting
Models
1 10
PRICING:
maximize
pro?t.
inflation forecast
108
US. Patent
Sheet 2 0f 13
US 7,392,201 B1
FIG. 2: Overview of information flows when performing service bureau work for a
client.
202
i
204
Fully develop
and
test the
l
206
actual pricing:
validate data
208
forecasting model
and
adjust for cost trend.
210
Recalibrate
the models
212
after
client's
3-6 months
undenlvriters
US. Patent
Sheet 3 of 13
US 7,392,201 B1
i
304
Fully develop
and
test the
305
Review information
on the
clients software
and
work ?ows
306
>
310
Collect updated
308
' _*
insurance to
and
renewing
groups
forecasting models
US. Patent
Sheet 4 0f 13
US 7,392,201 B1
402
Request:
I
I
I
Control totals
Layout
Customer sends
4'04
0
I
Layout
Sample database to test
Control totals
layout
406
Data
corresponds
408
41 0
Request full
database
Report problems to
customer and
request new test
data set or layout
US. Patent
Sheet 5 of 13
US 7,392,201 B1
502
product.
504
Estimate
Lag Period.
506
508
US. Patent
Sheet 6 0f 13
US 7,392,201 B1
Preparation of
612
database
614
SOURCE DATA
Shipped
@ A/ from
SOUl'C6
604
606
Values
Supplied
Read data,
produce and
by
616
check control
totals.
customer
Norms from
prior
608
610
experience
Time
periods
for
SAS
QFOUDS
DATASET
618
624
File data
outside of time
period
Not "1
time frame
Q~
22
6
Extract Universe
using time periods
626
620
Reformat
for
standardization
Compare data in
time periods to
standards
In time
Evaluate
Cause
Of
Mismatch
Prepare for
Match
Standards
Match and
Merge
632
US. Patent
Sheet 7 0f 13
US 7,392,201 B1
706
Generate
4%
lookup table
Compare to
prede?ned tames
+___>
Generate
lookup table
Merge
716
718
Produce person
level merged data
Flag people
720
with
enrollment &
Flag people
with
enrollment
\ Additional /
Checks
722
YES
726
Build
NO
724
Review
Analytic
With
Database
Customer
US. Patent
Sheet 8 0f 13
US 7,392,201 B1
FIG. 8: Aggregation of claims, risk factor coding, and additional data validation.
802
Sort into
temporal sequence of incurred
claim records
per person
804
803
'
Drop People
not
eligible for
analytic database
i
806
Code Risk Factors
808
Validation Checks
Valid
Data
YES
NO
Fix errors
Analytic Database
812
Or
810
Return to Customer
US. Patent
Sheet 9 0f 13
US 7,392,201 B1
901
902
Modeling universe
Winsorized data:
database
903
904
No claims
Ans/Claims
model
database
base
NO
YES
Claims
>
model
year
database
4-
908
912
Model
Regression tree
cont'nuous
or
data elements
other technique
only
i
910
defining terminal
nodes into regression
i
920
914
defining terminal
nodes into regression
Test models
and
saves
Test models
expectations
918
and
save
expectations
US. Patent
Sheet 10 0f 13
US 7,392,201 B1
Modeling universe
Claims
Model
1006
database
No claims
Any Claims
mode]
in base year
database
*T\
1008
Model
continuous
1
data elements
1014
only
Probability
tree
model
101(
Test
Model
1018
Test
Model
~>
1015
Logistic
Regression
Model
1015i
Probability
Tree
Model
1022
F___~____
node
003T
Model
102
101
Logistic
Regression
Model
1023
medians by terminal
node
Hm
US. Patent
Sheet 11 0113
US 7,392,201 B1
1106
1110
1112
Scores for
Scores for
Scores for
probability of
probability of
inliers
Scores for
inlier
outlier no
outlier claims
no claims
Claims
SCORING
1104
__C_>_LFl__IR_S_____
1108
Outlier
Outlier
means no
claims
_ _
means with
Clinical
* claims
1114
1116
Testing
1120
Aggregating to
complete next
year database
1118
4
modeling
Adjust for
1122
1124
person-level
cost trend
People not
included in
Aggregate to
Group-level
~>
Summary and
compare to
US. Patent
Jun. 24,2008
Sheet 12 0f 13
US 7,392,201 B1
1202
l
1204
Code group-level
risk factors:
benefit design,
SIC code, etc.
i
1206
G roup-level
regression tree
model of residual
l
1208
Regression
model at
group-level
i
1210
by adjusting
group-level
payment estimate.
US. Patent
Sheet 13 0f 13
US 7,392,201 B1
1302
1304
Group
Client Input:
-
Retention curve
cost
Administrative costs
estimate
margin
1306
Calculate
Redo
assumption
1308
is maximum pro?t
margin
acceptable?
Output expected
pro?t
and reconsider
assumptions
1310
1312
offertpnce
a
minimally
acceptable
pro?t
1314
Translate into
price per
subscriber unit
4_~
US 7,392,201 B1
1
CROSS-REFERENCE TO RELATED
APPLICATIONS
NAME OF FILE
DATE OF CREATION
SIZE IN BYTES
APPENDIX.TXT
281,991
The names above are the names of the ?les on the compact
disc, the dates are the dates the ?les were created on the
25
compact disk, and the siZe in bytes is the siZe of the ?le. Please
note that there is a glossary of terms included at the end of the
Background section.
30
35
40
45
for estimating costs and setting prices except for very small
groups, individual policies or speci?c medical stop loss insur
ance. Information on the insureds (i.e., individuals) medical
conditions is typically not used when group-level data are
forecast.
US 7,392,201 B1
3
words, these data are used to calculate the predictors for the
development model and are not used for underwriting actual
underwriter variability.
Frequently, aggregate stop loss medical insurance cov
ues from a model. The totals of both these values are equal to
25
underwriting period.
35
codes, type and place of service and provider type but not
40
this application)
45
insurance type.
reimbursement
50
which are usually minimal in the short run. Differs from pure
costs but it could be 110% or some other amount. The 55 price in?ation such as that measured in the consumer price
index (CPI).
only stop loss does not include speci?c stop loss. However,
credibility.
60
65
US 7,392,201 B1
5
25
surgical and medical care plus drug bene?ts for some plans.
35
calculate the predictors for the model that is used for under
45
50
55
ance.
subsequent to the base period and the lag period that contains
the data that comprise the dependent variable used in the
65
US 7,392,201 B1
8
data.
A further aspect of the invention contemplates a computer
20
25
30
model.
Yet another aspect of the invention is a computer-imple
mented process of developing a claim amount forecasting
model for use in forecasting the future claim amount for
members of a book of business, Where person-level data are
available for a substantial portion of the members of the book
of business for an actual base period, and the claim amount of
interest for forecasting purposes is an actual next period
Which can be, but is not necessarily contiguous With the actual
35
and
producing a group-level forecast for the actual underWrit
45
50
55
been reported.
Yet still another further aspect of the invention is a com
puter implemented process, Wherein claim amounts are a mix
forecasting model.
60
tiguous With the actual base period, comprising the steps of:
providing development universe data comprising person
level data for a statistically meaningful plurality of individu
als, Wherein the person-level data for an individual comprises
health care claims data for the individual and the data on a
health care claim comprises at least a claim amount and a
claim code;
WinsoriZing the person-level data to yield inlier data and
outlier data;
processing the inlier data to generate an inlier cost fore
casting model;
65
US 7,392,201 B1
10
producing a group-level forecast for the actual policy
period from the person-level forecasts of each individual or
member of the group by totaling the person-level cost fore
casts for the actual policy period.
comprising:
20
period and historical next period heath care claims data for a
25
data;
30
expected cost forecast for the policy period for each member
of the book of business; and
producing a group-level forecast for the expected cost of
the policy period from the person-level forecasts of each
person of the group by totaling the person-level expected cost
forecasts for the actual policy period.
A still further aspect of the invention is a computer-imple
mented process of forecasting costs attributable to claims
from members of a book of business during an actual policy
35
45
a claim code and the actual underWriting period can be, but is
50
policy period;
period based on the claim code associated With the health care
claim and providing at least one enrollment risk factor based
on the enrollment data;
60
65